Artamonov Mikhail Yu, LeBaron Tyler W, Pyatakovich Felix A, Minenko Inessa A
MJA Research and Development, Inc., East Stroudsburg, PA 18301, USA.
Department of Kinesiology and Outdoor Recreation, Southern Utah University, Cedar City, UT 84720, USA.
Pharmaceuticals (Basel). 2024 Apr 7;17(4):469. doi: 10.3390/ph17040469.
Stem cell therapy has emerged as a promising avenue for regenerative medicine, offering the potential to treat a wide range of debilitating diseases and injuries. Among the various types of stem cells, mesenchymal stem cells (MSCs) have garnered significant attention due to their unique properties and therapeutic potential. In recent years, researchers have been exploring novel approaches to enhance the effectiveness of MSC-based therapies. One such approach that has gained traction is the priming of MSCs with molecular hydrogen (H). This article delves into the fascinating world of mesenchymal stem cell priming with molecular hydrogen and the potential benefits it holds for regenerative medicine.
干细胞疗法已成为再生医学中一条充满希望的途径,为治疗多种使人衰弱的疾病和损伤提供了潜力。在各种类型的干细胞中,间充质干细胞(MSCs)因其独特的特性和治疗潜力而备受关注。近年来,研究人员一直在探索新方法以提高基于间充质干细胞疗法的有效性。一种受到关注的方法是用分子氢(H₂)对间充质干细胞进行预处理。本文深入探讨了用分子氢预处理间充质干细胞这一引人入胜的领域以及它在再生医学中所具有的潜在益处。